Latest Europe News

Hartshead Resources and joint venture partner RockRose Energy agree to a 28-day pause in procedural timelines for UK Southern Gas Basin Licence P2607, aiming to advance commercial discussions. The company remains committed to a constructive resolution while preserving its legal rights.

Neuren Pharmaceuticals reports a robust 11% rise in DAYBUE™ US net sales for Q1 2025, alongside a 17% jump in royalty income, setting the stage for an anticipated European market entry in early 2026.

Carnegie Clean Energy has partnered with global industrial leader SKF to co-develop and manufacture the Power Take-Off system for its CETO wave energy technology, marking a key step in commercialising ocean energy in Europe.

Orica Limited reported a 7.7% increase in revenue to $3.94 billion for the half year ended March 2025, but posted a net loss of $89 million due to significant impairment and restructuring charges. Excluding these items, net profit rose 40% to $250.8 million, with the board declaring a higher interim dividend.

Prospech Limited reports promising metallurgical test results from its Korsnäs Rare Earth Element resource, highlighting apatite as the dominant and well-liberated mineral. The company is fast-tracking bench-scale concentrate production and hydrometallurgical extraction to advance resource development.

EcoGraf Limited has been granted a second Australian patent for its HFfree® purification technology, reinforcing its position in the sustainable battery materials market. This patent extends protection for its innovative graphite purification process critical to lithium-ion battery anode production and recycling.

CLINUVEL Pharmaceuticals has completed recruitment for its Phase III trial of SCENESSE® in vitiligo patients with darker skin types, setting the stage for first results in late 2026. Early clinical observations suggest promising repigmentation outcomes.

Imdex Limited reported a stabilisation in global exploration activity after a prolonged downturn, highlighting resilience despite a 19% revenue dip in 3Q25 and outlining a growth strategy focused on technology and integrated solutions.

Unibail-Rodamco-Westfield and Cenomi Centers have entered a decade-long exclusive partnership to bring the Westfield brand to Saudi Arabia’s premier shopping centres, aiming to reshape retail experiences across the Kingdom’s largest cities.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Alterity Therapeutics has secured FDA Fast Track designation for ATH434, its lead candidate for treating Multiple System Atrophy, potentially speeding up regulatory review and bringing hope to patients with this rare neurodegenerative disorder.

Green Critical Minerals has secured a formal sample request from a leading European thermal management provider, marking a significant step in commercialising its VHD Graphite technology across multiple high-demand sectors.